Pegylated Liposomal Doxorubicin as a Induction Therapy for Lymphoma Induced Hemophagocytic Lymphohistiocytosis.
Clinical trial NCT04077905 · UNKNOWN
Trial details
- NCT number
- NCT04077905
- Sponsor
- Beijing Friendship Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-31
- Primary completion
- 2021-07-31
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.